Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N. Takahashi K, et al. Among authors: hojo m. Emerg Infect Dis. 2022 May;28(5):998-1001. doi: 10.3201/eid2805.220197. Epub 2022 Mar 15. Emerg Infect Dis. 2022. PMID: 35290176 Free PMC article.
A familial cluster of severe coronavirus disease 2019 that required intubation of all family members.
Katsuno T, Suzuki M, Ishikane M, Kinoshita N, Tsukada A, Morita C, Kusaba Y, Sakamoto K, Yamaguchi Y, Tsujimoto Y, Hashimoto M, Terada J, Takasaki J, Izumi S, Okuhama A, Ide S, Moriyama Y, Matsuda K, Takamatsu Y, Mitsuya H, Hojo M, Sugiyama H. Katsuno T, et al. Among authors: hojo m. Infect Dis (Lond). 2020 Oct;52(10):755-758. doi: 10.1080/23744235.2020.1784999. Epub 2020 Jul 2. Infect Dis (Lond). 2020. PMID: 32615051 No abstract available.
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers.
Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N, Sugiyama H. Katagiri D, et al. Among authors: hojo m. Crit Care Explor. 2020 Jul 31;2(8):e0170. doi: 10.1097/CCE.0000000000000170. eCollection 2020 Aug. Crit Care Explor. 2020. PMID: 32766565 Free PMC article.
Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion.
Kusaba Y, Izumi S, Takasaki J, Suzuki M, Katagiri D, Katsuno T, Matsumoto S, Sakamoto K, Hashimoto M, Ohmagari N, Katano H, Suzuki T, Hojo M, Sugiyama H. Kusaba Y, et al. Among authors: hojo m. Intern Med. 2020 Oct 1;59(19):2405-2408. doi: 10.2169/internalmedicine.5413-20. Epub 2020 Aug 29. Intern Med. 2020. PMID: 32863364 Free PMC article.
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Sugiyama M, et al. Among authors: hojo m. Gene. 2021 Jan 15;766:145145. doi: 10.1016/j.gene.2020.145145. Epub 2020 Sep 14. Gene. 2021. PMID: 32941953 Free PMC article.
COVID-19 can suddenly become severe: a case series from Tokyo, Japan.
Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki J, Asai Y, Terada M, Akiyama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S, Hayakawa K, Sugiyama H, Ohmagari N. Nakamura K, et al. Among authors: hojo m. Glob Health Med. 2020 Jun 30;2(3):174-177. doi: 10.35772/ghm.2020.01054. Glob Health Med. 2020. PMID: 33330803 Free PMC article.
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Kenji M, Takasaki J, Hojo M, Ishizaka Y, Ohmagari N. Kutsuna S, et al. Among authors: hojo m. J Infect Chemother. 2021 Jun;27(6):808-813. doi: 10.1016/j.jiac.2021.01.006. Epub 2021 Jan 18. J Infect Chemother. 2021. PMID: 33531292 Free PMC article.
Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR.
Tsujimoto Y, Terada J, Kimura M, Moriya A, Motohashi A, Izumi S, Kawajiri K, Hakkaku K, Morishita M, Saito S, Takumida H, Watanabe H, Tsukada A, Morita C, Yamaguchi Y, Katsuno T, Kusaba Y, Sakamoto K, Hashimoto M, Suzuki M, Takasaki J, Hojo M, Miyoshi-Akiyama T, Sugiyama H. Tsujimoto Y, et al. Among authors: hojo m. Infect Dis (Lond). 2021 Aug;53(8):581-589. doi: 10.1080/23744235.2021.1903550. Epub 2021 Mar 24. Infect Dis (Lond). 2021. PMID: 33760699 Free PMC article.
External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan.
Yamada G, Hayakawa K, Asai Y, Matsunaga N, Ohtsu H, Hojo M, Hashimoto M, Kobayashi K, Sasaki R, Okamoto T, Yanagawa Y, Katagiri D, Terada M, Suzuki M, Sato L, Miyazato Y, Ishikane M, Morioka S, Saito S, Ohmagari N. Yamada G, et al. Among authors: hojo m. J Infect Chemother. 2021 Jul;27(7):1043-1050. doi: 10.1016/j.jiac.2021.04.008. Epub 2021 Apr 12. J Infect Chemother. 2021. PMID: 33865699 Free PMC article.
HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
Khor SS, Omae Y, Nishida N, Sugiyama M, Kinoshita N, Suzuki T, Suzuki M, Suzuki S, Izumi S, Hojo M, Ohmagari N, Mizokami M, Tokunaga K. Khor SS, et al. Among authors: hojo m. Front Immunol. 2021 Apr 22;12:658570. doi: 10.3389/fimmu.2021.658570. eCollection 2021. Front Immunol. 2021. PMID: 33968060 Free PMC article.
535 results